In basal-type breast cancer cell lines RUNX2 promotes an osteomimetic phenotype and metastasis to the bone through transcriptional activation of osteopontin, MMPs, and VEGF [9–11]. This evidence concerns the gene RUNX2 and breast carcinoma.